Categories: HealthcareNews

Health Catalyst to Announce Fourth Quarter and Full Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SALT LAKE CITY, Feb. 14, 2023 (GLOBE NEWSWIRE) — Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2022 operating results on Tuesday, February 28, 2023, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Conference Call Details

The conference call can be accessed by dialing (800) 343-5172 for U.S. participants, or (785) 424-1699 for international participants, and referencing conference ID “HCAT Q422.” A live audio webcast will be available online at https://ir.healthcatalyst.com/. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Health Catalyst Investor Relations Contact:

Adam Brown
Senior Vice President, Investor Relations and FP&A
+1 (855)-309-6800
ir@healthcatalyst.com

Health Catalyst Media Contact:

Tarah Neujahr Bryan
Chief Marketing Officer
media@healthcatalyst.com  

Staff

Recent Posts

Phio Pharmaceuticals Announces Agreement with U.S. Manufacturing Source for Drug Substance

Agreement covers contract development and manufacturing of lead compound PH-762King of Prussia, Pennsylvania--(Newsfile Corp. -…

46 minutes ago

Scryb Announces Proposed Share Consolidation

Toronto, Ontario--(Newsfile Corp. - July 25, 2025) - Scryb Inc. (CSE: SCYB) ("Scryb" or the "Company")…

2 hours ago

RaySearch to present innovative news in RayStation, RayCare, and RayIntelligence at AAPM 2025

STOCKHOLM, July 25, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce its…

3 hours ago

CardioComm Solutions Announces Intention to Settle Outstanding Debt with Issuance of Shares

Toronto, Ontario--(Newsfile Corp. - July 25, 2025) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or…

8 hours ago

PDS Health and DEXIS Successfully Bring AI-Powered and 3D Imaging to More Than 1,000 Dental Practices Nationwide

Strategic collaboration brings advanced AI and CBCT imaging to more than 1,000 dental practices, enhancing…

15 hours ago

Exactech Reaches Consensual Agreement with Unsecured Creditors Committee, Completes Court Filing of Amended Plan

Plan Confirmation and Sale Approval Court Date Expected in Early September GAINESVILLE, Fla., July 24,…

15 hours ago